The small increases in SMN protein resulting from 2,4-DAQ exposure in SMA fibroblasts is consistent with previous work in SMA mice wherein these compounds show a modest increase in SMN protein in vivo [20–24]. The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.